Outcome of guideline directed pre-operative prophylactic single dose/day vs extended prophylactic antibotics for urological surgeries
Phase 4
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2024/03/063953
- Lead Sponsor
- Rajath S Shetty
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients undergoing elective urological surgeries under general anesthesia. Age =5 to = 75 years.
Exclusion Criteria
Patient refusing to consent to study or is unwilling to participate or with multiple comorbidities
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 30-day rate of clinical UTI after urological procedures with single dose/day preoperative antibiotic against extended antibiotic therapyTimepoint: At baseline, at 1 week after surgey and 30 days post surgey
- Secondary Outcome Measures
Name Time Method 1-week rate of clinical UTI, 1-week and 30-day bacteriuria rates, 1-week and 30-day asymptomatic bacteriuria rates, 1-week and 30-day septicemia rates <br/ ><br>Timepoint: 1 week, 30 days